FDA Brief

Warning letters Food

FDA warning letter to

The Bonami Baking Company, Inc.

High riskIssued Sep 7, 2022Posted Nov 22, 2022Division of Human and Animal Food Operations West V

FDA warns Bonami Baking over insanitary conditions, pest and allergen risks in ready-to-eat bakery products.

What happened

FDA inspected the Bonami Baking facility in Pittsburg, CA, on April 4-22, 2022, and found serious violations of food-manufacturing practice, preventive-control, and labeling rules. Investigators observed rodent excreta on ingredient bags, live ants, gaps and holes in the facility, allergen cross-contact from inadequate cleaning, and no complete food safety plan. FDA received the company's response on May 5, 2022, but found it incomplete for several issues.

What FDA found

  1. The firm did not have a food safety plan with required hazard analysis, preventive controls, supply-chain program, recall plan, monitoring, corrective action, or verification procedures.

    21 CFR 117.126(a)(1)-(2), 117.130(a)(2), 117.135(b), 117.139(a), 117.145(a), 117.150(a)(1), 117.165(b)
  2. The firm did not identify allergens as a hazard requiring a preventive control and did not control allergen cross-contact on shared equipment and utensils.

    21 CFR 117.130(a); 117.135(c)(2)
  3. The firm did not identify environmental pathogens such as Salmonella as a hazard for ready-to-eat products exposed after baking and lacked required environmental monitoring.

    21 CFR 117.130(c)(1)(ii); 117.165(a)(3)
  4. The firm did not validate oven bake times and temperatures or check thermometer and timer accuracy to control bacterial pathogens such as E. coli and Salmonella in wheat flour.

    21 CFR 117.160; 117.165(a)(1)
  5. The firm did not keep the plant clean and in repair or clean equipment safely, including using a non-food-contact chemical spray and drying equipment with a leaf blower near a dumpster.

    21 CFR 117.35(a)
  6. The firm did not exclude pests, with rodent excreta on ingredient bags, live ants, and gaps and holes in the facility.

    21 CFR 117.35(c)

What FDA wants

FDA asks the company to notify it in writing within 15 working days of receipt of the letter of specific steps taken to address the violations, with documentation and steps to prevent recurrence; if corrections cannot be completed in that time, the company must state why.

Who should pay attention

  • retailers and foodservice operators selling ready-to-eat bakery products from this facility
  • brands that buy baked goods from contract manufacturers
  • consumers with food allergies

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Tipical Latin Food, Corp. DBA La Pradera

    FDA warned La Pradera of Doral, Florida, that its ready-to-eat Venezuelan-style cheeses are adulterated; an inspection found no food safety plan and pests.

    High risk
  2. Middlefield Original Cheese Cooperative

    FDA warns Middlefield Original Cheese Cooperative about Listeria and insanitary conditions in its ready-to-eat cheese.

    High risk
  3. South Asian Food Inc.

    South Asian Food Inc. lacked seafood HACCP import verification and pest controls for imported dried seafood.

    High risk
  4. Mineral BioSciences, LLC

    Mineral BioSciences’ Totala and Ionicell supplements were flagged as unapproved new drugs and misbranded, with manufacturing violations.

    High risk